Germany vs Myanmar: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Germany
74.0%
in 2025
Myanmar
71.0%
in 2025
Germany rank
131st
Myanmar rank
133rd
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Germany
- Myanmar
How they compare
Germany currently reports 74.0% against 71.0% in Myanmar, a difference of 3.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Germany ahead.
Germany ranks 131st and Myanmar ranks 133rd of 194 countries.
Germany has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Germany | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 76.0% | 0.0% | 76.0% | Germany |
| 2010s | 83.2% | 28.4% | 54.8% | Germany |
| 2020s | 76.5% | 64.8% | 11.7% | Germany |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Germany or Myanmar?
- Germany, at 74.0% against 71.0% in Myanmar as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Germany and Myanmar?
- 3.0%, with Germany ahead.
- How many years of comparable data are there for Germany and Myanmar?
- 18 years are reported by both, from 2008 to 2025.
- How do Germany and Myanmar rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Germany ranks 131st and Myanmar ranks 133rd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.